Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer
2016 StandoutNobel
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Acute kidney injury
2012 Standout
Pathophysiology of Progressive Nephropathies
1998 Standout
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms
2006
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Continuous renal replacement therapy: A worldwide practice survey
2007
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Uremic Bleeding: Pathogenesis and Therapy
1998
Exercise Standards for Testing and Training
2013 Standout
Vitamin D Deficiency
2007 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
2007
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Chronic kidney disease
2011 Standout
Sarcoidosis
2013 Standout
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM
1995
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
2002
Acute kidney injury
2019 Standout
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Diabetes and Atherosclerosis
2002 Standout
Myocarditis
2011 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort
2014
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption
2005
Biomarkers of Drug-Induced Kidney Toxicity
2018
Ion Channels in Cell Proliferation and Apoptotic Cell Death
2005
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Influence of Clinical and Histological Features on Actuarial Renal Survival in Adult Patients With Idiopathic IgA Nephropathy, Membranous Nephropathy, and Membranoproliferative Glomerulonephritis: Survey of the Recent Literature
1992
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
2009 StandoutNobel
Chronic Kidney Disease
2016 Standout
Prevention of radiocontrast nephropathy
2005
Area Postrema: Chemoreceptor circumventricular organ of the medulla oblongata
1989
Myocarditis
2009 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin
2016
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Hyperosmolarity and CD95L trigger CD95/EGFR association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Rituximab for refractory granulomatous eye disease
2012
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Targeted Disruption of the Protein Kinase SGK3/CISK Impairs Postnatal Hair Follicle Development
2004
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure
1999
Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
1998
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
A review of the current use of rituximab in autoimmune diseases
2008
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Iron-Deficiency Anemia
2015 Standout
Causes and Consequences of Increased Sympathetic Activity in Renal Disease
2004
Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria
2004
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Bone metabolism and disease in chronic kidney disease
2003
Works of T. Risler being referenced
Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy.
1994
Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization
2004
Multifactorial genesis of enhanced platelet aggregability in patients with nephrotic syndrome
1989
The serine/threonine kinases SGK2 and SGK3 are potent stimulators of the epithelial Na+ channel α,β,γ-ENaC
2003
Up-Regulation of the Human Serum and Glucocorticoid-Dependent Kinase 1 in Glomerulonephritis
2002
Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease
2007
What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?
2004
Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients
2003
Rituximab for treatment-resistant extensive Wegener`s granulomatosis—additive effects of a maintenance treatment with leflunomide
2007
Association of Glomerular and Inerstitial Mononuclear Leukocytes with Different Forms of Glomerulonephritis
1990
Cellular taurine release triggered by stimulation of the Fas(CD95) receptor in Jurkat lymphocytes
1998
Comparative Pharmacokinetics and Pharmacodynamics of Loop Diuretics in Renal Failure
1994
Regulation of plasma aldosterone during hemodialysis
1990
Regulation of Plasma Aldosterone during Hemodialysis
1990
Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs.
1993
Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis.
1995
Do Different Dialysis-Membranes Affect Beta 2-Microglobulin Kinetics during Chronic Hemodialysis?
1994
Subpressor doses of angiotensin II do not increase albumin excretion in humans.
1996
Neurally mediated augmentation of arrhythmogenic properties of highly polar cardiac glycosides
1980
In Vivo Clearance and Elimination of Nine Marker Substances during Hemofiltration with Different Membranes
1992